Search
Generic filters

AGE – AgeX Therapeutics Inc

Not Compliant

The company is not compliant as it fails the financial ratios.

AgeX Therapeutics Inc. is a biotechnology company that is focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. The Company’s product pipeline includes two cell-based therapies, which is derived from telomerase-positive pluripotent stem cells (PSCs) and two product candidates, which is derived from its induced Tissue Regeneration (iTRTM) technology. The Company’s AGEX-BAT1 is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. Its AGEX-VASC1 is designed to restore vascular support in aged ischemic tissues, such as the aging heart. The Company’s iTRTM technology product candidates include AGEX-iTR1547, which is a drug-based formulation, and AGEX-iTR1550 (Renelon), which is a gene delivery technology.

AAOIFI ✗

Debt ÷ Market cap (MC)70.23
Non-Compliant Assets ÷ MC

Found the Stock You’re Looking For? Open an Account Today!

Opening an account has never been easier! Please fill out the form here and an advisor will be in touch to walk you through the process!

Still have some further questions?